Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.

Hamdy FC. and Donovan JL., (2023), Eur urol

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those withde novometastatic disease

Charlton P. et al, (2023)

Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.

Hamdy FC. and Donovan JL., (2023), Eur urol

Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies.

Cussenot O. et al, (2023), Curr opin urol

Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.

Rao SR. et al, (2023), Int j mol sci, 24

Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Cussenot O. et al, (2023), Bju int

Fifteen-Year Outcomes of the ProtecT Trial for Localized Prostate Cancer. Reply.

Hamdy FC. and Donovan JL., (2023), N engl j med, 389

Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).

Thorn JC. et al, (2023), Bmc health serv res, 23

Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk.

Cussenot O. et al, (2023), Bju int, 131, 745 - 754

Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.

Bryant RJ. et al, (2023), Bju int, 131, 694 - 704

Rbf/E2F1 control growth and endoreplication via steroid-independent Ecdysone Receptor signalling in Drosophila prostate-like secondary cells.

Sekar A. et al, (2023), Plos genet, 19

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Hamdy FC. et al, (2023), New england journal of medicine

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment

Donovan JL. et al, (2023), Nejm evidence

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological features

Rao SR. et al, (2023)

Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing?

Heidegger I. et al, (2023), Eur urol oncol, 6, 103 - 109

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.

Keeney E. et al, (2022), Pharmacoeconomics, 40, 1207 - 1220

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Buhigas C. et al, (2022), Mol cancer, 21

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).

Lane JA. et al, (2022), Bju int, 130, 370 - 380

Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo-Metastases to the bone (TRoMbone) trial.

Sooriakumaran P. et al, (2022), Bju int, 130, 43 - 53

Automated quality assessment of large digitised histology cohorts by artificial intelligence.

Haghighat M. et al, (2022), Sci rep, 12

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?